Global Tyrosine Kinase JAK Inhibitors Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 160386
- Pages: 150
-
Format:
Summary
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The global Tyrosine Kinase JAK Inhibitors market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Tofacitinib
Ruxolitinib
Baricitinib
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
CTI BioPharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Tyrosine Kinase JAK Inhibitors of Research
1.1.1 Definition
1.1.2 Specifications of Tyrosine Kinase JAK Inhibitors
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Tofacitinib Overview
1.2.1.2 Ruxolitinib Overview
1.2.1.3 Baricitinib Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Rheumatoid Arthritis (RA)
1.3.1.2 Polycythemia Vera (PCV)
1.3.1.3 Myelofibrosis (MF)
1.3.1.4 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Tofacitinib Market Size 2018-2023
3.1.1.1 Global Tofacitinib Market Size and Growth Rate 2018-2023
3.1.1.2 Global Tofacitinib Market Size by Region 2018-2023
3.1.2 Ruxolitinib Market Size 2018-2023
3.1.2.1 Global Ruxolitinib Market Size and Growth Rate 2018-2023
3.1.2.2 Global Ruxolitinib Market Size by Region 2018-2023
3.1.3 Baricitinib Market Size 2018-2023
3.1.3.1 Global Baricitinib Market Size and Growth Rate 2018-2023
3.1.3.2 Global Baricitinib Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Tofacitinib Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Tofacitinib Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Tofacitinib Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Ruxolitinib Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Ruxolitinib Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Ruxolitinib Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 Baricitinib Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global Baricitinib Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global Baricitinib Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Rheumatoid Arthritis (RA) Market Size 2018-2023
4.1.1.1 Global Rheumatoid Arthritis (RA) Market Size and Growth Rate 2018-2023
4.1.1.2 Global Rheumatoid Arthritis (RA) Market Size by Region 2018-2023
4.1.2 Polycythemia Vera (PCV) Market Size 2018-2023
4.1.2.1 Global Polycythemia Vera (PCV) Market Size and Growth Rate 2018-2023
4.1.2.2 Global Polycythemia Vera (PCV) Market Size by Region 2018-2023
4.1.3 Myelofibrosis (MF) Market Size 2018-2023
4.1.3.1 Global Myelofibrosis (MF) Market Size and Growth Rate 2018-2023
4.1.3.2 Global Myelofibrosis (MF) Market Size by Region 2018-2023
4.1.4 Others Market Size 2018-2023
4.1.4.1 Global Others Market Size and Growth Rate 2018-2023
4.1.4.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Rheumatoid Arthritis (RA) Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Rheumatoid Arthritis (RA) Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Rheumatoid Arthritis (RA) Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Polycythemia Vera (PCV) Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Polycythemia Vera (PCV) Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Polycythemia Vera (PCV) Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Myelofibrosis (MF) Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Myelofibrosis (MF) Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Myelofibrosis (MF) Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Others Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Tyrosine Kinase JAK Inhibitors Market Competition
7.1.1 Global Tyrosine Kinase JAK Inhibitors Market by Companies
7.1.2 Global Tyrosine Kinase JAK Inhibitors Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Pfizer
8.1.1 Pfizer Company Profile
8.1.2 Pfizer Product Portfolio
8.1.3 Pfizer Business Performance
8.1.4 Pfizer Development Overview
8.2 Incyte
8.2.1 Incyte Company Profile
8.2.2 Incyte Product Portfolio
8.2.3 Incyte Business Performance
8.2.4 Incyte Development Overview
8.3 Novartis
8.3.1 Novartis Company Profile
8.3.2 Novartis Product Portfolio
8.3.3 Novartis Business Performance
8.3.4 Novartis Development Overview
8.4 Eli Lilly
8.4.1 Eli Lilly Company Profile
8.4.2 Eli Lilly Product Portfolio
8.4.3 Eli Lilly Business Performance
8.4.4 Eli Lilly Development Overview
8.5 Gilead
8.5.1 Gilead Company Profile
8.5.2 Gilead Product Portfolio
8.5.3 Gilead Business Performance
8.5.4 Gilead Development Overview
8.6 Sanofi
8.6.1 Sanofi Company Profile
8.6.2 Sanofi Product Portfolio
8.6.3 Sanofi Business Performance
8.6.4 Sanofi Development Overview
8.7 Galapagos
8.7.1 Galapagos Company Profile
8.7.2 Galapagos Product Portfolio
8.7.3 Galapagos Business Performance
8.7.4 Galapagos Development Overview
8.8 AbbVie
8.8.1 AbbVie Company Profile
8.8.2 AbbVie Product Portfolio
8.8.3 AbbVie Business Performance
8.8.4 AbbVie Development Overview
8.9 Vertex
8.9.1 Vertex Company Profile
8.9.2 Vertex Product Portfolio
8.9.3 Vertex Business Performance
8.9.4 Vertex Development Overview
8.10 Teva
8.10.1 Teva Company Profile
8.10.2 Teva Product Portfolio
8.10.3 Teva Business Performance
8.10.4 Teva Development Overview
8.11 Astellas Pharma
8.11.1 Astellas Pharma Company Profile
8.11.2 Astellas Pharma Product Portfolio
8.11.3 Astellas Pharma Business Performance
8.11.4 Astellas Pharma Development Overview
8.12 Celgene
8.12.1 Celgene Company Profile
8.12.2 Celgene Product Portfolio
8.12.3 Celgene Business Performance
8.12.4 Celgene Development Overview
8.13 CTI BioPharma
8.13.1 CTI BioPharma Company Profile
8.13.2 CTI BioPharma Product Portfolio
8.13.3 CTI BioPharma Business Performance
8.13.4 CTI BioPharma Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
